IAPP
Islet amyloid polypeptide
Also known as: AMYLIN, DAP, IAP, IAPP_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P10997
- Gene
- IAPP
- Ensembl
- ENSG00000121351
- Chromosome
- 12
- Canonical length
- 89 aa
- Protein class
- Predicted intracellular proteins, Predicted secreted proteins
- Subcellular location
- Vesicles
- Secretome location
- Secreted to blood
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a member of the calcitonin family of peptide hormones. This hormone is released from pancreatic beta cells following food intake to regulate blood glucose levels and act as a satiation signal. Human patients with type 1 and advanced type 2 diabetes exhibit reduced levels of the encoded hormone in blood and pancreas. This protein also exhibits a bactericidal, antimicrobial activity. [provided by RefSeq, Jul 2016]
Canonical amino-acid sequenceUniProt
89 residues, UniProt reviewed canonical sequence.
>P10997|IAPP
1 MGILKLQVFL IVLSVALNHL KATPIESHQV EKRKCNTATC ATQRLANFLV HSSNNFGAIL
61 SSTNVGSNTY GKRNAVEVLK REPLNYLPLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against IAPP can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.56
- Highest tissue expression
- 157 nTPM
Expression across tissuesHPA
Tissue
- pancreas: 157 nTPM
- testis: 2.9 nTPM
- liver: 2.2 nTPM
- bone marrow: 1 nTPM
- skin: 0.7 nTPM
- adipose tissue: 0.4 nTPM
Single-cell type
- pancreatic islet cells: 1,973 nCPM
- late primary spermatocytes: 46 nCPM
- pancreatic acinar cells: 38 nCPM
- early spermatids: 27 nCPM
- mast cells: 9.6 nCPM
- late spermatids: 6.4 nCPM
Immune cell
- basophil: 0.3 nTPM
- neutrophil: 0.1 nTPM
- plasmacytoid DC: 0.1 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
Brain region
- thalamus: 2.5 nTPM
- midbrain: 2.2 nTPM
- cerebellum: 1.6 nTPM
- choroid plexus: 1.5 nTPM
- pons: 1.4 nTPM
- cerebral cortex: 1.3 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about IAPP.
Disease | ImmuneIEDB
Conditions an epitope on IAPP was assayed in.
- type 1 diabetes mellitus B and T cell
- type 2 diabetes mellitus B cell
ReferencesPubMed · IEDB
Publications for IAPP from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
1 publication
- Autoantibodies to islet amyloid polypeptide in diabetes.
1991 · Diabet Med · RCR 0.5 · 20 citations
Reference: B cellIEDB
1 publication
- Autoantibodies to islet amyloid polypeptide in diabetes.
1991 · Diabet Med · RCR 0.5 · 20 citations
Reference: T cellIEDB
4 publications
- Analysis of self-antigen specificity of islet-infiltrating T cells from human donors with type 1 diabetes.
2016 · Nat Med · RCR 9.1 · 276 citations - Recognition of HLA class I-restricted beta-cell epitopes in type 1 diabetes.
2006 · Diabetes · RCR 1.9 · 87 citations - Identification of Novel HLA-A*0201-restricted epitopes in recent-onset type 1 diabetic subjects and antibody-positive relatives.
2006 · Diabetes · RCR 1.4 · 73 citations - Glutamine deamidation does not increase the immunogenicity of C-peptide in people with type 1 diabetes.
2023 · J Transl Autoimmun · RCR 0.3 · 4 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. IEDB — curated epitope assays from the Immune Epitope Database (Vita et al., Nucleic Acids Research 2019). Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.93
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.2
- DepMap mean gene effect
- 0.04
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- amylin receptor 1 signaling pathway
- amylin receptor 2 signaling pathway
- amylin receptor 3 signaling pathway
- amylin receptor signaling pathway
- apoptotic process
- bone resorption
- cell-cell signaling
- eating behavior
- negative regulation of amyloid fibril formation
- negative regulation of bone resorption
- negative regulation of osteoclast differentiation
- negative regulation of protein-containing complex assembly
- osteoclast differentiation
- positive regulation of apoptotic process
- positive regulation of calcium-mediated signaling
- positive regulation of cAMP/PKA signal transduction
- positive regulation of MAPK cascade
- sensory perception of pain
- signal transduction
Molecular functions
- amyloid-beta binding
- hormone activity
- identical protein binding
- lipid binding
- receptor ligand activity
- signaling receptor binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of IAPP in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads IAPP as an antibody target. Whether an autoantibody or antibody against IAPP could matter depends on whether native IAPP is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
IAPP is annotated as secreted, so native IAPP circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label IAPP as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...